Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies
February 14th 2022Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.